EDGAR·FLOW

AIM ImmunoTech Inc. — Form 8-K

Filed November 18, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 28/100
What the filing says
AIM ImmunoTech adjourned its 2026 Annual Meeting of Stockholders scheduled for November 17, 2026 to December 8, 2026 at 11:00 A.M. ET because only 32.5% of outstanding shares were represented by proxy, falling short of the required 33.33% quorum threshold. The meeting will reconvene virtually on December 8, 2026 with no changes to the proposals; stockholders who have already voted need not take further action.
Why this rating

Quorum failure signals weak shareholder engagement and governance concern for a micro-cap ($6.4M). Routine administrative delay; no loss of assets or strategic harm, but reflects investor disengagement.

View original filing on SEC.gov ↗ AIM · stock on Yahoo Finance ↗

See more from November 18, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.